Garry Coulson

IBC Chair

Garry Coulson is a Registered Biosafety Professional with two decades’ experience in research and regulatory compliance in Academic, Government and Industry sectors. He holds an MS in Clinical Microbiology and a Ph.D in Infectious Diseases. Most recently, he served as the Biosafety Officer at the University of North Carolina at Chapel Hill. He is deeply passionate about public health and translational research that advances knowledge from the bench to the bedside. In his free time, he is an avid reader, fitness enthusiast, and volunteer pack mule for his sons’ regular fishing adventures.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.